ARQ 621
N-(3-aminopropyl)-N-[(1R)-1-(3-anilino-7-chloro-4-oxoquinazolin-2-yl)but-3-ynyl]-3-chloro-2-fluorobenzamide
Molecular Identity
ARQ 621
N-(3-aminopropyl)-N-[(1R)-1-(3-anilino-7-chloro-4-oxoquinazolin-2-yl)but-3-ynyl]-3-chloro-2-fluorobenzamide
PubChem CID: 25110841
2D Structure
Properties
C28H24Cl2FN5O2
Molecular Formula
552.40
Molecular Weight
g/mol
551.1291
Exact Mass
Da
5.3
XLogP
Above Lipinski threshold
91
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
6
H-Bond Acceptors
920
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
ARQ 621ARQ-621(R)-N-(3-AMINOPROPYL)-3-CHLORO-N-(1-(7-CHLORO-4-OXO-3-(PHENYLAMINO)-3,4-DIHYDROQUINAZOLIN-2-YL)BUT-3-YN-1-YL)-2-FLUOROBENZAMIDEUNII-UU55190C8SARQ 621 [WHO-DD]DTXSID80148974BENZAMIDE, N-(3-AMINOPROPYL)-3-CHLORO-N-((1R)-1-(7-CHLORO-3,4-DIHYDRO-4-OXO-3-(PHENYLAMINO)-2-QUINAZOLINYL)-3-BUTYN-1-YL)-2-FLUORO-Benzamide, N-(3-aminopropyl)-3-chloro-N-[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylamino)-2-quinazolinyl]-3-butyn-1-yl]-2-fluoro-RefChem:114164Eg5 inhibitor ARQ 621DTXCID0071465EG5 KINESIN-RELATED MOTOR PROTEIN INHIBITOR ARQ 6211095253-39-6C28H24Cl2FN5O2ARQ621
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to ARQ 621
Loading drug network...